Cathie Wood Bluebird Bio, Inc. Transaction History

Ark Investment Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$46.96 - $61.67 $1.89 Million - $2.48 Million	-40,200 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $4.05 Million - $6.34 Million	-68,141 Reduced 62.89%	40,200 $3.69 Million
Q2 2019 Jul 30, 2019	SELL	$75.84 - $105.21 $3.58 Million - $4.96 Million	-47,167 Reduced 30.33%	108,341 $13.8 Million
Q1 2019 May 13, 2019	SELL	$64.44 - $104.11 $2.67 Million - $4.31 Million	-41,430 Reduced 21.04%	155,508 $24.5 Million
Q4 2018 Feb 01, 2019	SELL	$59.1 - $93.26 $12 Million - $19 Million	-203,706 Reduced 50.84%	196,938 $19.5 Million
Q3 2018 Nov 07, 2018	BUY	$88.86 - $117.49 $12.2 Million - $16.1 Million	137,323 Added 52.15%	400,644 $58.5 Million
Q2 2018 Aug 07, 2018	BUY	$99.64 - $127.59 $6.57 Million - $8.41 Million	65,922 Added 33.4%	263,321 $41.3 Million
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $8.03 Million - $11.5 Million	75,937 Added 62.52%	197,399 $33.7 Million
Q4 2017 Feb 12, 2018	SELL	$81.25 - $130.7 $1.06 Million - $1.71 Million	-13,069 Reduced 9.71%	121,462 $21.6 Million
Q3 2017 Nov 09, 2017	BUY	$57.74 - $91.42 $857,323 - $1.36 Million	14,848 Added 12.41%	134,531 $18.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	37,021 Added 44.79%	119,683 $12.6 Million
Q1 2017 May 15, 2017	BUY	N/A	7,017 Added 9.28%	82,662 $7.51 Million
Q4 2016 Feb 13, 2017	BUY	N/A	75,645	75,645 $4.67 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.